Orforglipron is Eli Lilly’s weight-loss pill, and Bank of America expects it to enter the market in the second half of 2026 ...
Bausch + Lomb's stock remains a "Hold" despite the latest financial results. Here's what investors need to keep in mind.
What Happened? Shares of nutrition products company Bellring Brands (NYSE:BRBR) jumped 2.5% in the afternoon session after ...